CS Medica idea formation potential upsid

"I see 2 scenarios for CS Medica, the stock has broken out of a declining trend and there is potential for upside in TP Zone 1 and also TP Zone 2. As mentioned, these are potential thoughts, with many fundamentals also supporting a push, such as the listing of the subsidiary in Germany at a valuation of 30 million euros, while CS is currently valued at 65 million DKK."